Article Sidebar
Published:
Jan 20, 2022Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Mechanism of pharmacological effect of <i>Angelica essential oil</i> on anxiety based on network pharmacology and molecular docking
Abstract
Purpose: To investigate the pharmacological effect of Angelica essential oil (AEO) on anxiety disorder and the mechanism of action involved, using network pharmacology and molecular docking.
Method: Chemical compositions of AEO were determined using gas chromatography-mass spectrometry (GC-MS). The potential targets involved in the effect of AEO on anxiety were predicted by searching Bioinformatics databases. Cytoscape software was applied for networks construction. Analysis of Gene Ontology (GO) and pathway was done via R Programming Language, while molecular docking analysis was conducted by Autodock vina software.
Results: Network analysis showed that there were 10 bioactive components and 34 potential targets. The potential targets were distributed in cerebellar cortex, basic ganglia, hippocampal formation, amygdala, pons and medulla and liver. AEO was involved in multiple biological processes (BP), cell components (CC) and molecular functions (MF) associated with anxiety disorder. Molecular docking revealed good binding affinity between the major bioactive components and targets.
Conclusion: This study has revealed the pharmacological mechanism involved in the effect of AEO on anxiety, through network pharmacology and molecular docking. The pharmacological mechanism provides a firm theoretical basis for further studies in this area of research.
